Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Bibliografiska uppgifter
Huvudupphovsmän: Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D
Materialtyp: Conference item
Publicerad: 2009

Liknande verk